What Navigator NVGS flagged as biggest challenges ahead Navigator posts 339 EPS miss vs analyst estimates Gilead Sciences Inc GILD FDA Grants Priority Review for Investigational OnceDaily HIV SingleTablet Regimen BICLEN Is TScan Therapeutics TCRX stock worth taking a position in TScan Therapeutics posts narrower loss on 268 EPS beat CLX Clorox delivers Q1 2026 EPS above analyst forecasts stock rises 176 percent on positive investor reception PSA Public Storage posts 75 percent Q1 2026 EPS upside yet shares slip 103 percent in todays trading What impact investing US USEG Momentum Fading 20260501 TTEK Tetra Tech Q1 2026 EPS exceeds estimates by 42 percent shares rise 156 percent on positive investor sentiment Target Corporation TGT Bullish Thesis Underscores Structural Turnaround Potential and Attractive RiskReward Profile IRON Disc Medicine posts narrower than expected Q4 2025 loss shares rise slightly in todays trading session AAMI Acadian shares fall 276 after Q1 2026 EPS lands 248 below analyst consensus estimates